- Novo Nordisk experimental obesity pill has mild-to-moderate broadside effects successful aboriginal trial Reuters
- Daily pill cuts assemblage value by up to 13% aft 3 months successful aboriginal trial NBC News
- Ozempic shaper touts ‘remarkable,’ ‘more convenient’ caller pill that promises to assistance you shed up to 13% of your value successful 3 months New York Post
- Novo Nordisk’s amylin pill leads to important value nonaccomplishment successful aboriginal study STAT
- 'Ozempic pill' leads to faster, longer-lasting value nonaccomplishment than fashionable jabs, proceedings finds Daily Mail